Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Withaferin A Associated Differential Regulation of Inflammatory Cytokines.

Dubey S, Yoon H, Cohen MS, Nagarkatti P, Nagarkatti M, Karan D.

Front Immunol. 2018 Feb 9;9:195. doi: 10.3389/fimmu.2018.00195. eCollection 2018.

2.

Formulation of the bivalent prostate cancer vaccine with surgifoam elicits antigen-specific effector T cells in PSA-transgenic mice.

Karan D.

Vaccine. 2017 Oct 13;35(43):5794-5798. doi: 10.1016/j.vaccine.2017.09.037. Epub 2017 Sep 20.

3.

Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer.

Karan D, Tawfik O, Dubey S.

Sci Rep. 2017 Jun 29;7(1):4378. doi: 10.1038/s41598-017-04286-4.

4.

From Inflammation to Prostate Cancer: The Role of Inflammasomes.

Karan D, Dubey S.

Adv Urol. 2016;2016:3140372. doi: 10.1155/2016/3140372. Epub 2016 Jun 27. Review.

5.

Prostate immunotherapy: should all guns be aimed at the prostate-specific antigen?

Karan D.

Immunotherapy. 2013 Sep;5(9):907-10. doi: 10.2217/imt.13.83. Review. No abstract available.

6.

Combination immunotherapy with prostate GVAX and ipilimumab: safety and toxicity.

Karan D, Van Veldhuizen P.

Immunotherapy. 2012 Jun;4(6):577-80. doi: 10.2217/imt.12.53.

PMID:
22788125
7.

Inflammation-associated regulation of the macrophage inhibitory cytokine (MIC-1) gene in prostate cancer.

Dubey S, Vanveldhuizen P, Holzbeierlein J, Tawfik O, Thrasher JB, Karan D.

Oncol Lett. 2012 May;3(5):1166-1170. Epub 2012 Mar 6.

8.

Cancer immunotherapy: a paradigm shift for prostate cancer treatment.

Karan D, Holzbeierlein JM, Van Veldhuizen P, Thrasher JB.

Nat Rev Urol. 2012 May 29;9(7):376-85. doi: 10.1038/nrurol.2012.106. Review.

PMID:
22641164
9.

Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.

Karan D, Dubey S, Van Veldhuizen P, Holzbeierlein JM, Tawfik O, Thrasher JB.

Immunotherapy. 2011 Jun;3(6):735-46. doi: 10.2217/imt.11.59.

PMID:
21668311
10.

CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.

Lubaroff DM, Karan D.

Adv Drug Deliv Rev. 2009 Mar 28;61(3):268-74. doi: 10.1016/j.addr.2008.12.005. Epub 2009 Jan 7. Review.

PMID:
19166887
11.

Aqueous extract of Rhodiola imbricata rhizome stimulates Toll-like receptor 4, granzyme-B and Th1 cytokines in vitro.

Mishra KP, Ganju L, Chanda S, Karan D, Sawhney RC.

Immunobiology. 2009;214(1):27-31. doi: 10.1016/j.imbio.2008.04.001. Epub 2008 Jun 17.

PMID:
19159824
12.

Macrophage inhibitory cytokine-1: possible bridge molecule of inflammation and prostate cancer.

Karan D, Holzbeierlein J, Thrasher JB.

Cancer Res. 2009 Jan 1;69(1):2-5. doi: 10.1158/0008-5472.CAN-08-1230. Review.

14.

Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells.

Chen SJ, Karan D, Johansson SL, Lin FF, Zeckser J, Singh AP, Batra SK, Lin MF.

Prostate. 2007 Apr 1;67(5):557-71.

PMID:
17221842
15.

Decreased cytotoxic T cell activity generated by co-administration of PSA vaccine and CpG ODN is associated with increased tumor protection in a mouse model of prostate cancer.

Lubaroff DM, Karan D, Andrews MP, Acosta A, Abouassaly C, Sharma M, Krieg AM.

Vaccine. 2006 Aug 28;24(35-36):6155-62. Epub 2006 May 3.

PMID:
16876291
16.

Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.

Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, Karan D, Batra SK, Lin MF.

Endocr Relat Cancer. 2006 Mar;13(1):151-67.

PMID:
16601285
17.

Effect of leaf extract of Seabuckthorn on lipopolysaccharide induced inflammatory response in murine macrophages.

Padwad Y, Ganju L, Jain M, Chanda S, Karan D, Kumar Banerjee P, Chand Sawhney R.

Int Immunopharmacol. 2006 Jan;6(1):46-52. Epub 2005 Aug 26.

PMID:
16332512
18.

Anti-inflammatory activity of Seabuckthorn (Hippophae rhamnoides) leaves.

Ganju L, Padwad Y, Singh R, Karan D, Chanda S, Chopra MK, Bhatnagar P, Kashyap R, Sawhney RC.

Int Immunopharmacol. 2005 Nov;5(12):1675-84. Epub 2005 Apr 26.

PMID:
16102517
19.

Evolution of the AMP-forming acetyl-CoA synthetase gene in the Drosophilidae family.

Karan D, Lesbats M, David JR, Capy P.

J Mol Evol. 2003;57 Suppl 1:S297-303.

PMID:
15008428
20.

Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas.

Karan D, Lin FC, Bryan M, Ringel J, Moniaux N, Lin MF, Batra SK.

Int J Oncol. 2003 Nov;23(5):1365-71.

PMID:
14532978

Supplemental Content

Loading ...
Support Center